Sagimet Biosciences Inc. Series A Common Stock | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Posts

About This Stock More About This Stock
Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China
Article By: ChinaBio® Today
Saturday, January 27, 2024 1:40 PM EST
ArriVent BioPharma priced its upsized Nasdaq IPO at $18 dollars per share, raising $175 million. The company’s stated goal is to find promising novel assets from China and other countries, which it aims to bring to the US market.
In this article: BNTX, SGMT, AVBP Also: ASCLF
Read
Apogee, Sagimet Debut This Week In First Big IPOs Of Summer
Article By: The Fly
Sunday, July 16, 2023 1:58 PM EST
Sagimet and Apogee both made their trading debuts this week, raising cash for their clinical trials after upsizing their respective IPOs. Inflammation and immunology biotech Apogee had the larger of the two IPOs, as it raised $300 million.
In this article: SGMT, APGE, NETD, BOWN Also: GELYF, SFTBY, BABA
Read

Latest Tweets for $SGMT

No tweets yet!

PARTNER HEADLINES